Jiangsu Hengrui Pharmaceuticals Co.,Ltd (JHPCY OTCQB) stock market data APIs
$12.0305
0(0%)
as of September 11, 2026
Try our APIs with
free plan!
Jiangsu Hengrui Pharmaceuticals Co.,Ltd Financial Data Overview
Price chart is built with
Anychart
Jiangsu Hengrui Pharmaceuticals Co.,Ltd, a pharmaceutical company, researches, develops, manufactures, and commercializes medicines to address unmet clinical needs in China and internationally. The company develops medicines in the areas of oncology, metabolic and cardiovascular, immunological and respiratory, neuroscience, pain management, infectious, respiratory system, hematological, ophthalmology, and autoimmune and other diseases. The company was founded in 1970 and is headquartered in Lianyungang, China.
Prev. Close
12.0305
Open
12.0305
High
12.0305
Low
12.0305
52 wk Range
12-20
Market Cap
39 823 M
P/E Ratio
34.2857
Shares Outstanding
129 M
Revenue
32 564 M
EPS
0.0972
Beta
0.041
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Jiangsu Hengrui Pharmaceuticals Co.,Ltd data using free add-ons & libraries
Get Jiangsu Hengrui Pharmaceuticals Co.,Ltd Fundamental Data
Jiangsu Hengrui Pharmaceuticals Co.,Ltd Fundamental data includes:
- Net Revenue: 32 564 M
- EBITDA: 9 453 M
- Earnings Per Share: 0
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
Get Jiangsu Hengrui Pharmaceuticals Co.,Ltd Earnings data
Corporate Events Calendar & News package for
$
19.99
/mo.
What’s included:
- Latest Release: 2026-06-30
- EPS/Forecast: NaN
Get Jiangsu Hengrui Pharmaceuticals Co.,Ltd End-of-day data
EOD Historical Data package for
$
19.99
/mo.
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Jiangsu Hengrui Pharmaceuticals Co.,Ltd News
New
Heart drug developer Braveheart Bio surges on public debut after upsized IPO
[IPO Initial Public Offering on Financial Stock Market Chart 3D render] gonin Braveheart Bio (BRVE [https://seekingalpha.com/symbol/BRVE]), a clinical-stage drug developer focused on cardiovascular d...
Kailera falls after late-stage trial data for oral GLP-1 candidate
[Red dollar sign pointing down with arrow, concept of financial loss, market decline and recession, 3d render] Shares of Kailera Therapeutics (KLRA [https://seekingalpha.com/symbol/KLRA]) slipped mor...
GLP-1 developer Kailera, proteomics firm Alamar file for U.S. IPOs
[IPO Ahead Financial Growth] narvo vexar Weight loss drug developer Kailera Therapeutics (KLRA [https://seekingalpha.com/symbol/KLRA]) and Alamar Biosciences (ALMR [https://seekingalpha.com/symbol/AL...
Hengrui, Kailera phase 2 obesity pill results could pressure Eli Lilly's orforglipron
[Weight Loss Pill] Positive phase 2 results from Jiangsu Hengrui Pharmaceuticals (JNGHF [https://seekingalpha.com/symbol/JNGHF])(JHPCY [https://seekingalpha.com/symbol/JHPCY]) and privately held Kail...
Get Jiangsu Hengrui Pharmaceuticals Co.,Ltd fresh news feed via Financial News API
Corporate Events Calendar & News package for
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
Best Offer
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
